Beam Therapeutics Inc

Beam Therapeutics Inc

BEAM

Market Cap$2.01B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Beam Therapeutics IncBeam Therapeutics Inc-4.5--34%-0.2
$55.00

Target Price by Analysts

170.9% upsideBeam Therapeutics Target Price DetailsTarget Price
$-24.21

Current Fair Value

219.2% downside

Overvalued by 219.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.01 Billion
Enterprise Value$1.73 Billion
Dividend Yield$0 (0%)
Earnings per Share$-4.58
Beta2.08
Outstanding Shares87,975,311

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.54
PEG-42.3
Price to Sales-
Price to Book Ratio1.69
Enterprise Value to Revenue27.17
Enterprise Value to EBIT-3.96
Enterprise Value to Net Income-5
Total Debt to Enterprise0.14
Debt to Equity0.22

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Beam Therapeutics Inc